07:00 , Aug 24, 2015 |  BC Week In Review  |  Company News

New Zealand Pharmaceuticals, Fortress Biotech deal

New Zealand granted Fortress’ Altamira Bio subsidiary exclusive, worldwide rights to develop ManNAc to treat hereditary inclusion body myopathy (HIBM) and nephropathy. ManNAc was developed under a Cooperative Research and Development Agreement with NIH...
07:00 , Oct 13, 1997 |  BioCentury  |  Finance

Pipeline fill

Even though the industry raised $258 million last week, there's no shortage of financings in the pipeline. Bankers were tripping over themselves to get to the SEC, filing $308.2 million in biotech financings. The proposed...
07:00 , Jul 21, 1997 |  BioCentury  |  Emerging Company Profile

Gene Logic Inc.

Gene Logic Inc. Columbia, Md. Technology: Accelerated Target Discovery platform centered on READS system (Restriction Enzyme Analysis of Differentially expressed Sequences) Disease focus: Central nervous system disorders; osteoporosis; prostate, breast and colon cancer; heart failure; inflammatory...